Artificial Pancreas Improves Glucose Control by 15%, Benefits Type 1 Diabetes Patients
January 30, 2013 5:55 PM
comment(s) - last by
Continual glucose monitor (left), pump worn on the belt that injects insulin under the patient’s skin (right), and a controller (a handheld smart phone)
(Source: Institut de recherches cliniques de Montreal)
Type 1 diabetics are expected to benefit from the new dual-hormone treatment
type 1 diabetic
is a full-time job, but a system that acts as an artificial pancreas could offer a bit of relief for those struggling to keep their glucose regulated.
An IRCM research team, led by Dr. Rémi Rabasa-Lhoret, have performed the first trial that compares an artifical pancreas system to a traditional diabetes treatment, and found that the artificial pancreas resulted in better glucose control.
The artificial pancreas is a dual-hormone system that
and glucagon automatically through the use of a continuous glucose monitor (CGM) and advanced algorithm.
The algorithm obtains data from the CGM, and it calculates the amount of insulin required. It will also calculate the required glucagon, if needed. Insulin lowers blood sugar while glucagon raises it, preventing the diabetic from experiencing hypoglycemia. Hypoglycemia is the result of blood sugar dropping too low, and can result in confusion and even loss of consciousness.
Once the insulin and glucagon is calculated, the CGM sends it to the wireless pump, and it automatically administers the proper dose of the hormones.
While pumps are available to diabetics today, the sensors must be checked frequently and the pump's dosage must be adjusted. This new system does everything without any interference from the person wearing it.
"Approximately two-thirds of patients don't achieve their target range with current treatments," said Dr. Rabasa-Lhoret. "The artificial pancreas could help them reach these targets and reduce the risk of hypoglycemia, which is feared by most patients and remains the most common adverse effect of insulin therapy. In fact, nocturnal hypoglycemia is the main barrier to reaching glycemic targets."
In the study, 15 type 1 diabetic adults that used insulin pumps for at least three months prior to the study were sent to IRCM's facility for two, 15-hour visits. During the visits, their glucose levels were monitored as they exercised on a stationary bike. They were also given an evening meal and a snack, and were sent to bed.
It turns out that the addition of glucagon and the algorithm for calculated release helped participants avoid hypoglycemia during the night. In fact, those with the dual-hormone treatment had 15 percent better glucose control than those with conventional pump treatment.
the artificial pancreas
had an 8-fold reduction in the risk of hypoglycemia, and a 20-fold reduction in the risk of hypoglycemia during the night.
This article is over a month old, voting and posting comments is disabled
Knew it was coming...
1/31/2013 7:07:21 AM
I've been a diabetic for about uggghh, 20 years. I've been on a wireless insulin pump (Insulet Corps Omnipod) system since 2006. It's been fantastic. I'm not super active, but I didn't want wires hanging out and possibly being grabbed by something if I'm working in a server cabinet or whatever.
A couple of years ago, the specialist recommended a continuous blood sugar monitor...I always thought it was just a matter of time before someone put both pump and continuous monitor together in a package.
The pump has made my life MUCH MUCH easier and while there are considerations to be mindful of when you're wearing them, they are a godsend for keeping numbers more in line with where they need to be. With diabetes causing many health issues in the longterm, having tighter control from the outset almost alleviates all of them. Kudos for the ongoing research for a system like this.
"We don't know how to make a $500 computer that's not a piece of junk." -- Apple CEO Steve Jobs
FDA Releases New Guidelines to Speed Up Artificial Pancreas Development
December 2, 2011, 1:32 PM
Researchers Use Stem Cells to Treat Diabetes in Mice
February 21, 2008, 1:05 PM
Crunch Time For Diabetes Research
June 29, 2007, 12:54 AM
Microsoft Co-founder Paul Allen Donates $100M to Fight Raging Ebola Epidemic
October 23, 2014, 6:05 PM
Cool Science Video of the Day: Carnivorous Leech Eats Giant Jungle Worm
October 16, 2014, 6:44 PM
Facebook CEO and Founder, Mark Zuckerberg, Donates $25M to Fight Ebola
October 14, 2014, 5:06 PM
Chagrined Over Leaks, CDC Confirms First U.S. Ebola Diagnosis in Dallas, Texas
September 30, 2014, 5:55 PM
Nail Polish May Soon be Able to Detect Date Rape Drugs
August 26, 2014, 7:57 AM
SpaceX Falcon 9-R Rocket Suffers Malfunction, Self-Destructs During Test Flight
August 23, 2014, 9:36 AM
Most Popular Articles
Amid Theater Boycott Netflix Defiantly Plans New Movies, Plus 3 TV Shows for 2015
October 24, 2014, 7:30 PM
AT&T Defeats Purpose of New Apple SIM, Locks iPad Air 2 SIMs to Its Network
October 24, 2014, 2:17 PM
CVS, Rite Aid Kill Unofficial Apple Pay Support, Burn Google Wallet Users in the Process
October 25, 2014, 5:26 PM
1 Million Credit Card Activated on Apple Pay Within 72 Hours, Walmart CEO Hopes Visa "Suffers"
October 28, 2014, 8:17 AM
Microsoft's Figures Show Desktop Users Flocking to Windows 10 Preview
October 27, 2014, 11:04 AM
Latest Blog Posts
Costco Gives Employees Thanksgiving Off; Wal-Mart Leads "Black Thursday" Charge
Oct 29, 2014, 9:57 PM
"Bear Selfies" Fad Could Turn Deadly, Warn Nevada Wildlife Officials
Oct 28, 2014, 12:00 PM
The Surface Mini That Was Never Released Gets "Hands On" Treatment
Sep 26, 2014, 8:22 AM
ISIS Imposes Ban on Teaching Evolution in Iraq
Sep 17, 2014, 5:22 PM
Space Terrorism is a Looming Threat For the United States
Apr 23, 2014, 7:47 PM
More Blog Posts
Copyright 2014 DailyTech LLC. -
Terms, Conditions & Privacy Information